[July 17, 2014]

ATTENTION LANNETT SHAREHOLDERS: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Lannett Company, Inc.

Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Lannett Company, Inc. (NYSE: LCI) and certain of its officers. Lannett develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products.

Specifically, Johnson & Weaver's investigation seeks to determine if Lannett, through its business practices, violated antitrust laws.

On July 16, 2014, the Company made known that it has received interrogatories and a subpoena from State of Connecticut Office of the Attorney General in connection with an investigation into pricing of digoxin, a treatment used for congestive heart failure. The Attorney General's investigation will sek to determine "whether anyone engaged in any activities that resulted in (a) fixing, maintaining or controlling prices of digoxin or (b) allocating and dividing customers or territories relating to the sale of digoxin in violation of Connecticut antitrust law." On the news, Lannett shares declined more than 17 percent on July 16, 2014.

If you are a Lannett shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If you email, please include your phone number.

About Johnson & Weaver, LLP:

Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California and New York. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

[ Back To TMCnet.com's Homepage ]